Determination of HER2 Amplification Status on Tumour DNA by Digital PCR

被引:29
作者
Garcia-Murillas, Isaac [1 ]
Lambros, Maryou [1 ]
Turner, Nicholas C. [1 ,2 ]
机构
[1] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England
[2] Royal Marsden Hosp, Breast Unit, London SW3 6JJ, England
关键词
POLYMERASE CHAIN-REACTION; BREAST-CANCER; IN-SITU; HYBRIDIZATION; RECEPTOR;
D O I
10.1371/journal.pone.0083409
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Determination of the presence of HER2 amplification by quantitative PCR has been challenging, in part due to chromosomal instability and identification of a robust a reference region. We assessed the potential of digital PCR for highly accurate assessment of DNA concentration with EFTUD2 as chromosome 17 reference probe. We assessed a HER2: EFTDU2 ratio by digital PCR assay in the microdissected DNA from 18 HER2 amplified and 58 HER2 non-amplified cancers. The HER2: EFTUD2 ratio had high concordance with conventionally defined HER2 status with a sensitivity of 100% (18/18) and a specificity of 98% (57/58). The HER2: EFTUD2 digital PCR assay has potential to accurately assess HER2 amplification status.
引用
收藏
页数:4
相关论文
共 19 条
[1]   Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories [J].
Baehner, Frederick L. ;
Achacoso, Ninah ;
Maddala, Tara ;
Shak, Steve ;
Quesenberry, Charles P., Jr. ;
Goldstein, Lynn C. ;
Gown, Allen M. ;
Habel, Laurel A. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) :4300-4306
[2]  
Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO
[3]  
2-L
[4]   Genetic characterisation of invasive breast cancer:: a comparison of CGH and PCR based multiplex microsatellite analysis [J].
Buerger, H ;
Schmidt, H ;
Beckmann, A ;
Zänker, KS ;
Boecker, W ;
Brandt, B .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (11) :836-840
[5]   The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups [J].
Curtis, Christina ;
Shah, Sohrab P. ;
Chin, Suet-Feung ;
Turashvili, Gulisa ;
Rueda, Oscar M. ;
Dunning, Mark J. ;
Speed, Doug ;
Lynch, Andy G. ;
Samarajiwa, Shamith ;
Yuan, Yinyin ;
Graef, Stefan ;
Ha, Gavin ;
Haffari, Gholamreza ;
Bashashati, Ali ;
Russell, Roslin ;
McKinney, Steven ;
Langerod, Anita ;
Green, Andrew ;
Provenzano, Elena ;
Wishart, Gordon ;
Pinder, Sarah ;
Watson, Peter ;
Markowetz, Florian ;
Murphy, Leigh ;
Ellis, Ian ;
Purushotham, Arnie ;
Borresen-Dale, Anne-Lise ;
Brenton, James D. ;
Tavare, Simon ;
Caldas, Carlos ;
Aparicio, Samuel .
NATURE, 2012, 486 (7403) :346-352
[6]   High False- Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study [J].
Dabbs, David J. ;
Klein, Molly E. ;
Mohsin, Syed K. ;
Tubbs, Raymond R. ;
Shuai, Yongli ;
Bhargava, Rohit .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) :4279-4285
[7]   Mathematical Analysis of Copy Number Variation in a DNA Sample Using Digital PCR on a Nanofluidic Device [J].
Dube, Simant ;
Qin, Jian ;
Ramakrishnan, Ramesh .
PLOS ONE, 2008, 3 (08)
[8]   Genomics-Driven Oncology: Framework for an Emerging Paradigm [J].
Garraway, Levi A. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15) :1806-1814
[9]   Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR [J].
Gevensleben, Heidrun ;
Garcia-Murillas, Isaac ;
Graeser, Monika K. ;
Schiavon, Gaia ;
Osin, Peter ;
Parton, Marina ;
Smith, Ian E. ;
Ashworth, Alan ;
Turner, Nicholas C. .
CLINICAL CANCER RESEARCH, 2013, 19 (12) :3276-3284
[10]   Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samples [J].
Heredia, Nicholas J. ;
Belgrader, Phillip ;
Wang, Shenglong ;
Koehler, Ryan ;
Regan, Jack ;
Cosman, Angela M. ;
Saxonov, Serge ;
Hindson, Benjamin ;
Tanner, Stephanie C. ;
Brown, Alexandra S. ;
Karlin-Neumann, George .
METHODS, 2013, 59 (01) :S20-S23